Cardiol Therapeutics (CRDL) Institutional Ownership $1.40 -0.04 (-2.43%) As of 01:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cardiol Therapeutics (NASDAQ:CRDL)CurrentInstitutional OwnershipPercentage12.49%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$3.98MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$381.74K Get CRDL Insider Trade Alerts Want to know when executives and insiders are buying or selling Cardiol Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CRDL Institutional Buying and Selling by Quarter Cardiol Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/13/2025Tejara Capital Ltd3,194,990$3.10M1.2%+2.6%3.868% 5/12/2025MMCAP International Inc. SPC782,625$759K0.1%-1.6%0.947% 4/18/2025Lion Street Advisors LLC333,725$318K0.1%+8.5%0.404% 2/21/2025PVG Asset Management Corp487,295$624K3.0%N/A0.590% 2/17/2025Cetera Investment Advisers43,547$56K0.0%N/A0.053% 2/14/2025AdvisorShares Investments LLC882,488$1.13M0.2%-24.6%1.068% 2/13/2025Envestnet Asset Management Inc.309,684$398K0.0%N/A0.375% 2/11/2025Virtu Financial LLC48,031$61K0.0%N/A0.058% 2/10/2025Tejara Capital Ltd3,115,437$3.99M2.6%+75.9%3.771% 2/6/2025Atria Investments Inc135,891$174K0.0%N/A0.164% Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/6/2025Jones Financial Companies Lllp19,847$25K0.0%N/A0.024% 1/27/2025Lion Street Advisors LLC307,666$396K0.1%+12.6%0.372% 11/15/2024Jane Street Group LLC14,759$29K0.0%N/A0.018% 11/13/2024Townsquare Capital LLC13,745$27K0.0%N/A0.017% 10/24/2024 Wealth Enhancement Advisory Services LLC13,700$27K0.0%N/A0.020% 10/21/2024Foundations Investment Advisors LLC161,950$321K0.0%+237.4%0.235% 10/10/2024Lion Street Advisors LLC273,281$544K0.2%+7.9%0.396% 8/8/2024AdvisorShares Investments LLC1,466,972$2.93M0.5%+12.7%2.126% 8/2/2024Foundations Investment Advisors LLC48,000$97K0.0%N/A0.069% 7/17/2024 Baader Bank Aktiengesellschaft29,028$59K0.0%N/A0.042% 7/12/2024Lion Street Advisors LLC253,281$505K0.2%+31.4%0.367% 5/10/2024MMCAP International Inc. SPC2,566,125$4.65M0.6%-13.1%3.758% 2/14/2024AdvisorShares Investments LLC1,189,978$1M0.2%-1.3%1.821% 2/9/2024AXS Investments LLC697,651$579K0.1%-9.8%1.068% 11/15/2023Tejara Capital Ltd645,457$578K0.3%+29.9%0.996% 11/15/2023Laird Norton Trust Company LLC100,000$90K0.0%+63.1%0.154% 11/13/2023Tejara Capital Ltd645,457$578K0.4%+29.9%0.996% 11/6/2023AdvisorShares Investments LLC1,205,788$1.11M0.3%-1.1%1.861% 10/10/2023FNY Investment Advisers LLC33,305$30K0.0%N/A0.051% 8/11/2023Tejara Capital Ltd497,061$442K0.2%+12.8%0.775% 8/10/2023AXS Investments LLC1,299,076$1.16M0.3%-24.8%2.026% 8/9/2023AdvisorShares Investments LLC1,219,738$1.09M0.3%+3.4%1.902% 8/2/2023Bank of Montreal Can112,179$110K0.0%N/A0.175% 7/13/2023Cambridge Investment Research Advisors Inc.76,611$68K0.0%+66.5%0.120% 5/12/2023AXS Investments LLC1,727,827$844K0.3%N/A2.698% 5/11/2023MMCAP International Inc. SPC3,153,400$1.54M0.3%-6.0%4.924% 5/9/2023AdvisorShares Investments LLC1,179,738$575K0.2%+7.2%1.842% 2/9/2023 Mirae Asset Global Investments Co. Ltd.1,094,040$557K0.0%+25.7%1.708% 2/1/2023Bank of Montreal Can90,000$61K0.0%+511.0%0.141% 8/15/2022MMCAP International Inc. SPC3,353,400$4.43M0.4%+3.1%5.414% Trump’s Next Trade War Bombshell (Ad)NVIDIA's "Next Multi-trillion-dollar Industry" Forget generative AI. Jensen Huang — CEO of NVIDIA — believes THIS breakthrough tech is "the next multi-trillion-dollar industry" Jeff Bezos, Mark Zuckerberg, and Peter Thiel all have positions… And Elon Musk even said: "If you've got [this technology] there is no meaningful limit to the size of the economy." And there's still a small window of time to get in at the ground floor.Click here to see why billionaires are betting on this tech.8/11/2022Marble Harbor Investment Counsel LLC38,150$50K0.0%+32.0%0.062% 8/2/2022Thompson Davis & CO. Inc.28,400$37K0.0%N/A0.046% 7/26/2022 Mirae Asset Global Investments Co. Ltd.1,356,620$1.78M0.0%-2.3%2.190% 6/2/2022 Mirae Asset Global Investments Co. Ltd.1,388,836$2.15M0.0%+32.9%2.243% 5/11/2022MMCAP International Inc. SPC3,253,400$4.98M0.3%+3.2%7.294% 2/9/2022MMCAP International Inc. SPC3,153,200$5.83M0.4%N/A7.069% 1/25/2022Private Ocean LLC20,651$38K0.0%+275.5%0.046% 1/11/2022Brookstone Capital Management15,887$27K0.0%N/A0.036% 11/12/2021Renaissance Technologies LLC144,900$598K0.0%N/A0.334% 11/12/2021Vident Investment Advisory LLC50,566$208K0.0%N/A0.117% 11/10/2021Marble Harbor Investment Counsel LLC22,000$91K0.0%N/A0.051% 11/5/2021Advisor Group Holdings Inc.15,800$65K0.0%N/A0.036% (Data available from 1/1/2016 forward) CRDL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CRDL shares? During the previous two years, 19 institutional investors and hedge funds held shares of Cardiol Therapeutics. The most heavily invested institutionals were Tejara Capital Ltd ($3.10M), AdvisorShares Investments LLC ($1.13M), MMCAP International Inc. SPC ($759K), PVG Asset Management Corp ($624K), AXS Investments LLC ($579K), Envestnet Asset Management Inc. ($398K), and Foundations Investment Advisors LLC ($321K).Learn more on Cardiol Therapeutics' institutional investors. What percentage of Cardiol Therapeutics' stock is owned by institutional investors? 12.49% of Cardiol Therapeutics' stock is owned by institutional investors. Learn more on CRDL's institutional investor holdings. Which institutional investors have been buying Cardiol Therapeutics' stock? Of the 17 institutional investors that purchased Cardiol Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tejara Capital Ltd ($1.78M), PVG Asset Management Corp ($487.30K), Envestnet Asset Management Inc. ($309.68K), AdvisorShares Investments LLC ($204.99K), Foundations Investment Advisors LLC ($161.95K), Lion Street Advisors LLC ($141.03K), and Atria Investments Inc ($135.89K). How much institutional buying is happening at Cardiol Therapeutics? Institutional investors have bought a total of 2,917,607 shares in the last 24 months. This purchase volume represents approximately $3.98M in transactions. Which of Cardiol Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Cardiol Therapeutics stock in the last 24 months: AdvisorShares Investments LLC ($288.38K), and MMCAP International Inc. SPC ($13K). How much institutional selling is happening at Cardiol Therapeutics? Institutional investors have sold a total of 301,381 shares in the last 24 months. This volume of shares sold represents approximately $381.74K in transactions. Related Companies RGNX Major Shareholders SVRA Major Shareholders TECX Major Shareholders FULC Major Shareholders SLDB Major Shareholders PASG Major Shareholders PRTC Major Shareholders SNDL Major Shareholders ERAS Major Shareholders CMPX Major Shareholders This page (NASDAQ:CRDL) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRDL Stock Alerts